DCLRE1B promotes tumor progression and predicts immunotherapy response through METTL3-mediated m6A modification in pancreatic cancer

BACKGROUND: DCLRE1B is a 5’-to-3’ exonuclease, which is involved in repairing ICL-related DNA damage. DCLRE1B has been reported to cause poor prognosis in a variety of cancers. Nonetheless, there is no research on DCLRE1B’s biological role in pan-cancer datasets. Thus, ascertaining the processes via...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Lincheng, Wang, Fei, Deng, Zhaoda, Zhang, Gong, Zhu, Lin, Zhao, Zhiming, Liu, Rong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629169/
https://www.ncbi.nlm.nih.gov/pubmed/37936074
http://dx.doi.org/10.1186/s12885-023-11524-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10629169/
https://www.ncbi.nlm.nih.gov/pubmed/37936074
http://dx.doi.org/10.1186/s12885-023-11524-8

Ejemplares similares